Monitoring early response to chemoradiotherapy with (18)F-FMISO dynamic PET in head and neck cancer

PURPOSE: There is growing recognition that biologic features of the tumor microenvironment affect the response to cancer therapies and the outcome of cancer patients. In head and neck cancer (HNC) one such feature is hypoxia. Here we investigated the utility of (18)F-fluoromisonidazole (FMISO) dynam...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Nucl Med Mol Imaging
Asıl Yazarlar: Grkovski, Milan, Lee, Nancy Y., Schöder, Heiko, Carlin, Sean D., Beattie, Bradley J., Riaz, Nadeem, Leeman, Jonathan E., O’Donoghue, Joseph A., Humm, John L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563902/
https://ncbi.nlm.nih.gov/pubmed/28540417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3720-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller